Pivotal Therapeutics Inc. Reports 1st Quarter 2012 Results

Published: May 29, 2012

WOODBRIDGE, Ontario, May 28, 2012 (GLOBE NEWSWIRE) -- Pivotal Therapeutics Inc. (OTCQX:PVTTF) (CNSX:PVO), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease, today announced its financial results and operational highlights for the three months ended ended March 31, 2012. All dollar amounts referenced herein are in Canadian dollars unless otherwise stated.

Back to news